Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Federal Rules of Evidence, Rule 502, at September 26, 2007

if it is approved, is it retro-active?  Meaning would the rule affect us in a negative way by allowing state level AC/P info. to be used in federal cases?

Not sure I understood it all.

Thank you for your help........it is really appreciated.

D2006S

Share
New Message
Please login to post a reply